Magnetothermal-activated gene editing strategy for enhanced tumor cell apoptosis

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Targeted apoptosis induction in tumor cells is crucial for solid tumor treatment.
• Current methods like ablation and gene editing risk damaging healthy tissues.
• Developing precise cancer therapies with minimal side effects remains a significant challenge.

Purpose of the Study:

• To develop a magnetothermal-induced CRISPR-Cas9 gene editing system for targeted tumor cell apoptosis.
• To investigate the synergistic therapeutic effect of dual-genome editing and mild hyperthermia.
• To provide a precise and safe cancer treatment strategy with reduced damage to normal tissues.

Main Methods:

• Fabrication of a magnetothermal nanoparticulate platform using ZnCoFe2O4@ZnMnFe2O4 nanoparticles.
• Surface modification with polyethyleneimine (PEI) and hyaluronic acid (HA) for plasmid DNA loading.
• Application of an alternating magnetic field to induce mild hyperthermia (42°C) and trigger CRISPR-Cas9 gene editing.

Main Results:

• The system successfully achieved targeted knockout of HSP70 and BCL2 genes in tumor cells.
• The mild magnetothermal effect enhanced tumor cell apoptosis through both gene editing and direct heat sensitization.
• The strategy demonstrated precise activation of CRISPR-Cas9, leading to synergistic therapeutic effects with minimal damage to adjacent tissues.

Conclusions:

• The magnetothermal-induced CRISPR-Cas9 system offers a precise and effective approach for cancer therapy.
• This dual-action strategy enhances tumor cell apoptosis while preserving normal tissue integrity.
• This novel system presents a promising new avenue for developing safer and more effective cancer treatments.